Renal Cancer - Results from #2360

Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma. November 25, 2020

Improving segmentation accuracy of CT kidney cancer images using adaptive active contour model. November 24, 2020

Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma. November 24, 2020

Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. November 24, 2020

Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies. November 23, 2020

Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing. November 23, 2020

Expression of T-cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. November 23, 2020

Prospective geriatric assessment for perioperative risk stratification in partial nephrectomy. November 20, 2020

Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma. November 20, 2020

First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center. November 20, 2020

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma. November 19, 2020

Robot-assisted partial nephrectomy: 7-year outcomes. November 19, 2020

Robot-assisted versus open surgery for radical nephrectomy with level 1-2 vena cava tumor thrombectomy : a French monocenter experience (UroCCR study #73). November 19, 2020

Systemic Analysis and Review of Nivolumab-ipilimumab Combination as a Rescue Strategy for Renal Cell Carcinoma After Treatment With Anti-PD-1/PD-L1 Therapy. November 18, 2020

European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma. November 18, 2020

Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors. November 18, 2020

Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response. November 17, 2020

Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization. November 17, 2020

Renal Neoplasia with Papillary Architecture Involving the Pelvicalyceal System. November 17, 2020

Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. November 16, 2020

Page 119 of 456